Skip to main content
. 2022 Aug 29;22:715. doi: 10.1186/s12879-022-07693-9

Table 6.

Summary of adverse events in the two groups

Groups Nephrotoxicity (n, %) Hepatotoxicity (n, %) Peripheral neuropathy (n, %) QTc prolongation (n,%) Leukopenia (n, %) hypokalemia (n, %) Ototoxicity (n, %) Others (n, %) p value
Bdq group (n=102) 12 (11.8) 9 (8.8) 3 (3.0) 3(3.0) 2 (2.0) 2 (2.0) 2 (2.0) 4 (3.9) 0.21
Non-Bdq group (n=100) 3 (3.0) 2 (2.0) 1 (1.0) 2(2.0) 2 (2.0) 1 (1.0) 8 (8.0) 7 (7.0)